Here we consider the novel hypothesis that, despite its ability to promote myocyte survival, the elevation of FGF21 in T2D is not beneficial, but deleterious, such that in the context of T2D elevated FGF21 promotes pathological concentric cardiac hypertrophy. This evidence concerns the gene FGF21 and cardiac hypertrophy.